¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"connective tissue activating peptide III"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® connective tissue ÇÑ±Û °áÇÕÁ¶Á÷
¼³¸í   
  Ã¼³»¿¡ ³Î¸® ºÐÆ÷Çϸç, Àå±â, Á¶Á÷»çÀ̸¦ ¸Þ¿ì°í ±×°ÍÀ» ±â°èÀûÀ¸·Î ÁöÁö, Á¶Á÷ÀÌ´Ù. ±×¹Û¿¡ Ç÷°ü, ¸²ÇÁ°ü, ½Å°æÀ» ÀεµÇϸ砿µ¾ç, ´ë»ç»ê¹°ÀÇ ¼ö¼Û ¶Ç´Â Àú·ù, ³ª¾Æ°¡¼­´Â ¼Õ»ó, °¨¿°¿¡ ´ëÇÑ ¹æ¾î ¶Ç´Â ¼öº¹ µî¿¡µµ ÀÛ¿ëÇÑ´Ù. °áÇÕÁ¶Á÷Àº ¼¼Æ÷°£ÁúÀ̠dzºÎÇϸç, ¼¼Æ÷°£ÁúÀ» ±¸¼ºÇϴ ±âÁú°ú ¼¶À¯ÀÇ ¼º»ó¿¡ µû¶ó °£¿±Á¶Á÷, ¼¶À¯¼º °áÇÕÁ¶Á÷(¼º±ä¼¶À¯¼º °áÇÕÁ¶Á÷, ÃÎÃÎÇÑ ¼¶À¯¼º °áÇÕÁ¶Á÷), Áö¹æÁ¶Á÷, Åº¼ºÁ¶Á÷, ¼¼¸Á Á¶Á÷ µîÀ¸·Î ºÐ·ùµÈ´Ù.
  
  
¿µ¹® peptide ÇÑ±Û ÆéƼµå
¼³¸í   
  µÎ °³ÀÌ»óÀÇ ¾Æ¹Ì³ë»ê ºÐÀÚ »çÀÌ¿¡¼­, ÇÑÂÊÀÇ ¾Æ¹Ì³ë±â¿Í ´Ù¸¥ ÂÊÀÇ Ä«¸£º¹½Ç±â°¡ ¹° ºÐÀÚ¸¦ ÀÒÀ¸¸é¼­ ÃàÇÕÇÏ¿© ÀÌ·ç´Â ¾Æ¹Ìµå °áÇվƹ̳ë»êÀÇ ¼ö°¡ 2, 3, ¡¦ ÀΠ°æ¿ì, °¢°¢ µðÆéƼµå, Æ®¸®ÆéƼµå, ¡¦µîÀ¸·Î ºÎ¸£¸ç, ¿©·¯ °³ÀÇ ¾Æ¹Ì³ë»êÀ¸·Î ±¸¼ºµÇ´Â °ÍÀ» ¿Ã¸®°íÆéƼµå, À̺¸´Ù Å« °ÍÀ» Æú¸®ÆéƼµå¶ó°í ÇÑ´Ù. Á÷¼â»óÀÇ °ÍÀÌ ¸¹Áö¸¸, È¯»ó ±¸Á¶¸¦ °®´Â ÆéƼµåµµ ÀÖ´Ù. ÀúºÐÀÚÀÇ ÆéƼµå´Â ¹°, »ê, ¾ËÄ®¸® µûÀ§¿¡ Àß ³ì°í ¾ËÄڿÿ¡´Â ³ìÁö ¾ÊÀ¸³ª, °íºÐÀÚÀÇ ÆéƼµå´Â ¹°¿¡ Àß ³ìÁö ¾Ê°í ´Ü¹éÁú°ú ¼ºÁúÀÌ ºñ½ÁÇÏ´Ù. ³úÇϼöüȣ¸£¸ó, ºê¶óµðŰ´Ñ µî°ú °°ÀÌ »ý¸®Àû±â´ÉÀÌ ÇöÀúÇÑ °ÍÀº »ý¸®È°¼ºÆéƼµå(bioactive peptide)¶ó°í ÇÑ´Ù.
¿µ¹® osseous tissue ÇÑ±Û »ÀÁ¶Á÷, °ñÁ¶Á÷
¼³¸í   
  °ñ¼¼Æ÷¿Í °ñ¼¼Æ÷ÁÖÀ§ÀÇ µüµüÇÑ Ä®½·Á¶Á÷À¸·Î µÑ·¯½ÎÀΠ¹ÐÁýµÈ °áÇÕÁ¶Á÷À» ¶æÇÑ´Ù. ÀÌ °ñÁ¶Á÷¿¡ ÀÇÇØ¼­ »À°¡ ÀÌ·ç¾îÁ® ÀÎüÀÇ °ñ°ÝÀ» Çü¼ºÇÑ´Ù.
¿µ¹® epithelial tissue ÇÑ±Û »óÇÇÁ¶Á÷
¼³¸í   
  »óÇǴ ÇÑ Ãþ ¶Ç´Â ¿©·¯ ÃþÀÇ ¼¼Æ÷·Î ÀÌ·ç¾îÁø ÆÇ ¸ð¾çÀÇ ±¸Á¶·Î ½ÅüÀǠǥ¸é°ú °ü»ó±¸Á¶ÀÇ ³»°­À» µÑ·¯½Î°í ÀÖ´Ù. »óÇǼ¼Æ÷¿Í »óÇǼ¼Æ÷»çÀÌÀÇ ÀûÀº ¾çÀ¸·Î Á¸ÀçÇÏ¿© »óÇÇ»çÀÌÀÇ °ø°£À» Ã¤¿ì°í Àִ ¼¼Æ÷°£ÁúÀ» ÇÕÃÄ »óÇÇÁ¶Á÷À̶ó ÇÑ´Ù. »óÇÇÁ¶Á÷¿¡´Â ¿øÄ¢ÀûÀ¸·Î Ç÷°üÀÌ ºÐÆ÷µÇ¾î ÀÖÁö ¾Ê´Ù.
¿µ¹® granulation tissue ÇÑ±Û À°¾ÆÁ¶Á÷
¼³¸í   
  ¸ð¼¼Ç÷°üÀ̠dzºÎÇϸ砿ռºÇϰԠÁõ½ÄÀ» °è¼ÓÇϴ ¾î¸° °áÇÕÁ¶Á÷. Ã¢»ó µî Á¶Á÷ °á¼Õ¿¡ ´ëÇÑ ¼öº¹, À̹°Ã³¸®ÀÇ ±âÁúÈ­, ¿°ÁõÀÌ ¸¸¼ºÀûÀΠ°æ°ú¿¡ Àְųª Á¾¾çÁõ½Ä¿¡ µ¿¹ÝµÈ »çÀ̹°ÁúÀÇ ¹ÝÀÀ¼º ¿°Áõ¿¡¼­ °üÂûµÈ´Ù. ±¸¼º¼ººÐÀº »ý±äÁö ¾ó¸¶ ¾ÈµÇ´Â ¾î¸° À°¾ÆÁ¶Á÷Àº ¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä, »õ·Î »ý±ä ¸ð¼¼Ç÷°ü°ú ¿©·¯ À¯ÁÖ¼¼Æ÷ ¹× ´Ù¸¥ Áß°£¿±¼¼Æ÷(¹éÇ÷±¸, ¸²ÇÁ±¸, ÇüÁú¼¼Æ÷, Á¶Á÷±¸, ´ÜÇÙ±¸, °Å´ë¼¼Æ÷)µîÀ¸·Î ±¸¼ºµÈ´Ù. À̰ÍÀÌ ½Ã°£ÀÌ Áö³ª ±×¸®µÇ¸é, ¸ð¼¼Ç÷°ü°ú À¯ÁÖ¼¼·Î, ´Ù¸¥Á¶Á÷¼ººÐÀ» °¨¼Ò½ÃÄÑ ¸¸¼ºÈ­ÇÏ¿© ¿À·¡µÈ À°¾Æ°¡ µÇ¸ç °á±¹Àº ¼¶À¯¼¼Æ÷¿Í ¾Æ±³Áú¼¶À¯·Î ±¸¼ºµÈ ¹ÝÈçÁ¶Á÷À¸·Î º¯ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • connective tissue fiber
    °áÇÕÁ¶Á÷¼¶À¯
  • connective tissue nevus
    °áÇÕÁ¶Á÷¸ð¹Ý
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • factor III
    Á¦3ÀÎÀÚ
  • conglutinogen activating factor
    ±³Âø¿øÈ°¼ºÀÎÀÚ
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • lymphocyte-activating determinant
    ¸²ÇÁ±¸È°¼º°áÁ¤ÀÎÀÚ
  • macrophage-activating factor
    Å«Æ÷½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ, ´ë½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • connective
    °áÇÕ-, ¿¬°á-
  • atrial natriuretic peptide
    ½É¹æ³ªÆ®·ýÀÌ´¢ÆéƼµå
  • brain natriuretic peptide
    ³ú³ªÆ®·ýÀÌ´¢ÆéƼµå
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • connective tissue
    °áÇÕÁ¶Á÷
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • peptide
    ÆéƼµå
  • atrial natriuretic peptide
    ½É¹æ³ªÆ®·ýÀÌ´¢ÆéƼµå
  • tissue plasminogen activator
    Á¶Á÷Çö󽺹̳ë°ÕȰ¼ºÁ¦
  • tissue
    Á¶Á÷
  • adipose tissue
    Áö¹æÁ¶Á÷
  • elastic tissue
    ź·ÂÁ¶Á÷
  • erectile tissue
    ¹ß±âÁ¶Á÷
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • lymphatic tissue
    ¸²ÇÁÁ¶Á÷
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷
  • muscular tissue
    ±ÙÀ°Á¶Á÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • connective tissue fiber
    °áÇÕÁ¶Á÷¼¶À¯
  • connective tissue nevus
    °áÇÕÁ¶Á÷¸ð¹Ý
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´, ½Â¸ðÆÇ¸·º´
  • brain natriuretic peptide
    ³ú³ªÆ®·ýÀÌ´¢ÆéƼµå
  • peptide bond
    ÆÕƼµå°áÇÕ
  • catabolite activating protein
    ÀÌÈ­»ê¹°È°¼ºÈ­´Ü¹é
  • conglutinogen activating factor
    ±³Âø¿øÈ°¼ºÀÎÀÚ
  • lymphocyte-activating determinant
    ¸²ÇÁ±¸È°¼º°áÁ¤±â
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • macrophage-activating factor
    Å«Æ÷½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • gastrin-releasing peptide
    °¡½ºÆ®¸°À¯¸®ÆéƼµå
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • general connective tissue
    ÀϹݰáÇÕÁ¶Á÷.
  • pigment connective tissue
    »ö¼Ò°áÇÕÁ¶Á÷
  • primitive connective tissue
    ¿ø½Ã°áÇÕÁ¶Á÷(¡­Ì¿ùêðÚòÄ) °£¿±(Êàç¨) .
  • regular connective tissue
    ±ÔÄ¢¼º °áÇÕÁ¶Á÷, Á¤Çü°áÇÕÁ¶Á÷(ïáû¡Ì¿ùêðÚòÄ).
  • procollagen III peptide
    ÇÁ·ÎÄݶó°Õ III ÆéƼµå
  • BNP=> brain natriuretic peptide
    ³ú ³ªÆ®·ý ÀÌ´¢ ÆéƼµå
  • GIP (Gastric inhibitory peptide)
    À§Àå¾ïÁ¦(êÖíóåäð¤) ÆéŸÀ̵å
  • GRP (Gastrin-releasing peptide)
    °¡½ºÆ®¸°-ºÐºñÆéÆÄÀ̵å
  • Gastric inhibitory peptide
    À§¾ïÁ¦(êÖåäð¤)È£¸£¸ó
  • Gastrin-releasing peptide
    °¡½ºÆ®¸°ºÐºñÆéŸÀ̵å
  • General anesthesia, reticular activating system and.
    Àü½Å¸¶Ãë(îïãóئö­), ¸Á»óüȰ¼ºÈ­°è(ØÑßÒô÷üÀàõûùͧ)
  • PAF =platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
  • PAF= platelet activating factor
    Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
  • T cell activating factor
    T¼¼Æ÷Ȱ¼ºÀÎÀÚ
  • VIP : vasoactive intestinal peptide
    Ç÷°üÀÛ¿ë ¼ÒÀåÆéŸÀ̵å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • procollagen III peptide
    ÇÁ·ÎÄݶó°Õ III ÆéƼµå
  • cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • collagenous connective tissue
    ¾Æ±³°áÇÕÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷(¡­ðÚòÄ).
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷ ¼¼Æ÷
  • connective tissue cells
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷ Áúȯ(¡­òðü´)
  • connective tissue disease,mixed
    È¥ÇÕ¼º(ûèùêàõ)
  • connective tissue fiber
    °áÇÕÁ¶Á÷ ¼¶À¯
  • connective tissue fibers
    °áÇÕÁ¶Á÷¼¶À¯
  • connective tissue hyperplasia
    °áÇÕÁ¶Á÷Áõ½Ä
  • connective tissue nevus
    °áÇÕÁ¶Á÷¸ð¹Ý
  • connective tissue of endometrium
    ÀڱüӸ·°áÇÕÁ¶Á÷
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Loose collagenous connective tissue
    ¼º±ä¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼Ò¼º°áÇÕÁ¶Á÷
  • Reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼¸Á°áÇÕÁ¶Á÷
  • Cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • Collagenous connective tissue
    ¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ±³¿ø°áÇÕÁ¶Á÷
  • Dense collagenous connective tissue
    Ä¡¹Ð¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Ä¡¹Ð°áÇÕÁ¶Á÷
  • Elastic connective tissue
    ź·Â°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ź·Â°áÇÕÁ¶Á÷
  • Connective tissue fibers
    °áÇÕÁ¶Á÷¼¶À¯
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¶À¯
  • Connective tissue cells
    °áÇÕÁ¶Á÷¼¼Æ÷
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¼Æ÷
  • Pigment connective tissue
    »ö¼Ò°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] »ö¼ÒÁ¶Á÷
  • Connective tissue of endometrium
    ÀڱüӸ·°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Àڱ󻸷°áÇÕÁ¶Á÷
  • Mucous connective tissue
    Á¡¾×°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Á¡¾×°áÇÕÁ¶Á÷
  • Third arch (III)
    ¼Â°±ÁÀÌ
    [¿¾ ¿ë¾î] Á¦»ï±Ã
  • Oculomotor nerve (III)
    ´«µ¹¸²½Å°æ
    [¿¾ ¿ë¾î] µ¿¾È½Å°æ
  • Spongy bone tissue [Trabecular bone tissue]
    ÇØ¸é»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] ÇØ¸é°ñÁ¶Á÷
  • Skeletal muscular tissue
    °¡·Î¹«´Ì±ÙÀ°Á¶Á÷ [»À´ë±ÙÀ°Á¶Á÷]
    [¿¾ ¿ë¾î] °ñ°Ý±ÙÁ¶Á÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilharzial granulation tissue
    ¹æ±¤ÁÖÇ÷ÈíÃæÀ°¾ÆÁ¶Á÷
  • tissue parasite
    Á¶Á÷±â»ýÃæ
  • tissue selectivity
    Á¶Á÷¼±Åüº
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activating enzyme
    "ºÎȰȿ¼Ò (Ý·üÀý£áÈ), Ȱ¼ºÈ­È¿¼Ò (üÀàõûùý£áÈ)"
  • acyl activating enzyme
    ¾Æ½ÇºÎȰȿ¼Ò (Ý·üÀý£áÈ)
  • amino acid activating enzyme
    ¾Æ¹Ì³ë»ê(ß«) Ȱ¼ºÈ­(üÀàõûù) È¿¼Ò(ý£áÈ)
  • DNA polymerase III
    DNA Æú¸®¸Ó·¹À̽º III
  • enzyme III
    È¿¼Ò(ý£áÈ) III
  • exonuclease III
    ¿¢¼Ò´©Å¬¸®¿¡À̽º III
  • fatty acid activating enzyme
    Áö¹æ»ê Ȱ¼ºÈ­ È¿¼Ò (ò·Û¸ß«üÀàõûùý£áÈ)
  • HTLV-III
    (å²) human T cell lymphostrophic virus
  • platelet-activating factor
    Ç÷¼ÒÆÇȰ¼º ÀÎÀÚ(úìá³÷ùüÀàõì×í­)
  • ribonuclease III
    ¶óÀ̺¸´ºÅ¬¸®¿¡À̽º III
  • adipose tissue
    Áö¹æÁ¶Á÷(ò·Û¸ðÚòÄ)
  • brown adipose tissue
    °¥»öÁö¹æÁ¶Á÷(Êèßäò·Û¸ðÚòÄ)
  • established tissue chluture
    ¼ö¸³ Á¶Á÷¹è¾ç (â§Ø¡ðÚòÄÛÆå×)
  • lipoprotein tissue factor
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) Á¶Á÷ÀÎÀÚ(ðÚòÄì×í­)
  • median tissue culture dose
    Á¤ÁßÁ¶Á÷¹è¾ç·®(ïáñéðÚòÄÛÆå×Õá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • connective tissue
    °áÇÕÁ¶Á÷
  • proper connective tissue
    °íÀ¯°áÇÕÁ¶Á÷
  • reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
  • aberrant breast tissue
    ¹ÌÀÔÀ¯¹æÁ¶Á÷
  • areolar tissue
    À±¹®»óÁ¶Á÷
  • fibrous tissue
    ¼¶À¯¼ºÁ¶Á÷
  • flowing tissue
    À¯µ¿Á¶Á÷, ±â·ù¼ºÁ¶Á÷
  • free water in stationary tissue
    Á¤ÀûÁ¶Á÷³» ÀÚÀ¯¼öºÐ
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • inflammatory tissue
    ¿°ÁõÁ¶Á÷
  • interstitial tissue
    °£ÁúÁ¶Á÷
  • lattice in stationary tissue
    Á¤ÀûÁ¶Á÷³»°ÝÀÚ
  • MALT(mucosa associated lymphoid tissue)
    Á¡¸·°ü·Ã¸²ÇÁÁ¶Á÷
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷, °£¿±Á¶Á÷
  • muscle tissue
    ±ÙÀ°Á¶Á÷, ±ÙÁ¶Á÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
CTAP computed tomography in arterial portography; connective tissue activating peptide
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
AT III angiotensin III; antithrombin III
ML I, II, III, IV mucolipidosis I, II, III, IV
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CTAP III Connective tissue activating peptide III
CTAP Connective Tissue Activating Peptides
P-III-P precollagen-III-peptide
CTD Connective Tissue Diseases
CTGF Connective Tissue Growth Factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cellular connective tissue
    ¼¼Æ÷¼º °áÇÕ Á¶Á÷
    ¼¼Æ÷·Î »çÀ̰¡ ¿¬°áµÇ¾î ÀÖ´Â Á¶Á÷.
  • connective tissue
    °áÇÕÁ¶Á÷
    ´Ù¸¥ Á¶Á÷µéÀ» ÁöÁöÇÏ°í ¿¬°áÇϸç, ¿©·¯ ½Åü ±¸Á¶¹°À» ÁöÁöÇÏ´Â Á߹迱¼º Á¶Á÷À¸·Î¼­ ź¼º ¼¶À¯ °áÇÕÁ¶Á÷À̳ª ±³¿ø ¼¶À¯ °áÇÕÁ¶Á÷, °ñ Á¶Á÷°ú ¿¬°ñ Á¶Á÷À» Æ÷ÇÔÇÑ´Ù. °áÇÕ Á¶Á÷Àº ¿¬°ñÀ» Á¦¿ÜÇϰí´Â Ç÷°üÀÌ Ç³ºÎÇÏ´Ù.
  • connective tissue disease
    °áÇÕÁ¶Á÷ º´, °áÇÕÁ¶Á÷ Áúȯ
  • connective tissue fiber
    °áÇÕ Á¶Á÷ ¼¶À¯
  • connective tissue sheath of Key and Retzius
    Ű-·¹Ä¡¿ì½ºÀÇ °áÇÕ Á¶Á÷ ÃÊ
    ½Å°æ³»¸·, ƯÈ÷ ½Å°æ¼¶À¯ Á¾¸»Áö ÁÖÀ§ÀÇ ¾ãÀº ¿¬Àå.
  • dense connective tissue
    Ä¡¹Ð °áÇÕÁ¶Á÷
    ±³¿ø¼¶À¯°¡ dzºÎÇÏ°Ô °¡µæ Â÷ ÀÖ´Â °áÇÕÁ¶Á÷.
  • dense fibrous connective tissue
    Ä¡¹Ð ¼¶À¯¼º °áÇÕ Á¶Á÷
  • fibrous connective tissue
    ¼¶À¯¼º °áÇÕ Á¶Á÷
  • hyalin connective tissue
    È÷¾Ë¸° °áÇÕ Á¶Á÷
  • interposition of connective tissue
    °áÇÕ Á¶Á÷ÀÇ °³ÀÔ
  • modified connective tissue
    º¯Çü °áÇÕÁ¶Á÷
  • primitive connective tissue
    ¿ø½Ã °áÇÕ Á¶Á÷
  • reticular connective tissue
    ¼¼¸Á °áÇÕ Á¶Á÷
  • macrophage activating factor
    ´ë½Ä ¼¼Æ÷ Ȱ¼º ÀÎÀÚ
  • platelet-activating factor
    Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
connective tissue activating peptide III Cytokine, produced from platelet basic protein, that acts as a growth factor.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anionic neutrophil activating peptide <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
granule cell of connective tissue <cell biology, immunology> Resident cell of connective tissue that contains many granules rich in histamine and heparan sulphate.
Release of histamine from mast cells is responsible for the immediate reddening of the skin in a weal and flare response. Very similar to basophils and possibly derived from the same stem cells.
Two types of mast cells are now recognised, those from connective tissue and a distinct set of mucosal mast cells, the activities of the latter are T-cell dependent.
(05 Jan 1998)
mixed connective tissue disease <syndrome> A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon.
The disease is differentially characterised by high serum titres of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen (nuclear ribonucleoprotein) and a speckled epidermal nuclear staining pattern on direct immunofluorescence.
A more modern term for this condition is the undifferentiated connective tissues disease.
(22 Sep 2002)
mucous connective tissue A type of connective tissue little differentiated beyond the mesenchymal stage; its ground substance of glycoproteins is abundant and contains fine collagenous fibres and fibroblasts; in its most characteristic form, it appears in the umbilical cord as Wharton's jelly.
Synonym: gelatinous tissue.
(05 Mar 2000)
connective tissue <pathology> Rather general term for mesodermally derived tissue that may be more or less specialised. Cartilage and bone are specialised connective tissue, as is blood, but the term is probably better reserved for the less specialised tissue that is rich in extracellular matrix (collagen, proteoglycan etc.) and that surrounds other more highly ordered tissues and organs.
(18 Nov 1997)
connective tissue cell Any of the cell's of varied form occurring in connective tissue.
(05 Mar 2000)
connective tissue cells The cellular elements of the fibrous and nonfibrous components of the various forms of connective tissue.
(12 Dec 1998)
connective tissue disease <rheumatology> A heterogeneous group of diseases characterised by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
They include rheumatoid arthritis, systemic lupus erythematosus, rheumatic fever, scleroderma and others, that are sometimes referred to as rheumatic diseases.
They do not solely affect connective tissues but they are autoimmune in origin. Rheumatic fever and rheumatoid arthritis were first proposed as such disease's, and other so-called collagen disease's have been added.
(18 Jul 2002)
connective tissue group <physiology> A collective name for mucous tissue, dentin, bone, cartilage, and ordinary connective tissue, all derived from the mesenchyme.
(05 Mar 2000)
skin and connective tissue diseases A collective term for diseases of the skin and its appendages and of connective tissue.
(12 Dec 1998)
neoplasms, connective and soft tissue Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.
(12 Dec 1998)
neoplasms, connective tissue Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.
(12 Dec 1998)
Lillie's allochrome connective tissue stain <technique> A procedure using PAS, haematoxylin, picric acid, and methyl blue; used for distinction between basement membrane and reticulin, and for demonstration of arteriosclerotic lesions.
(05 Mar 2000)
connective The part of an anther that connects the lobes.
(09 Oct 1997)
connective tumour <oncology> Any tumour of the connective tissue group, such as osteoma, fibroma, sarcoma.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • connective tissue
    °áÇÕ Á¶Á÷
  • peptide
    ÆéŸÀ̵å;µÑ ÀÌ»óÀÇ ¾Æ¹Ì³ë»ê °áÇÕ¹°
  • connective
    Á¢¼ÓÀÇ
  • connective
    Á¢¼ÓÀûÀÎ;°áÇÕ(¿¬Á¢)¼ºÀÇ;¿¬°á¹°;¿¬Á¢¹°;¿¬°á¾î(Á¢¼Ó»ç.°ü°è»çµî);¿¬°á±âÈ£;~ly ¿¬°áÇÏ¿©;Á¢¼ÓÀûÀ¸·Î
  • tissue
    Á¶Á÷
  • cleansing tissue
    È­Àå¿ë ¹Ú¿±Áö(Ƽ½´ ÆäÀÌÆÛ)
  • facial tissue
    °í±Þ È­ÀåÁö
  • permanent tissue
    ¿µ±¸ Á¶Á÷
  • tissue
    Á¶Á÷;¾ãÀº Á÷¹°;(°ÅÁþ¸» µûÀ§ÀÇ)µÚ¹ü¹÷;¿¬¼Ó;ź¼Ò ÀÎÈ­Áö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á